secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2026-06-10T20:15:42+00:00
Accession:  0001104659-26-072343
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrana Health shareholders approve 1M-share increase to 2024 equity plan, re-elect all nine directors
--------------------------------------------------------------------------------

- Shareholders approved an amendment to the 2024 Equity Incentive Plan, increasing shares reserved by 1,000,000 to a total of 5,100,000 shares.
- All nine director nominees were elected, including Kenneth Sim, Thomas Lam, John Chiang, Weili Dai, Linda Dong, J. Lorraine Estradas, Mitchell Kitayama, Matthew Mazdyasni, and David Schmidt.
- Ernst & Young was ratified as independent auditor for FY 2026 with 43.7M votes for, and the say-on-pay proposal passed with 34.1M votes for.
- The share reserve increase extends the plan term to March 24, 2036; the plan originally effective from 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465926072343/0001104659-26-072343-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465926072343/tm2614755d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-072343

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer